Lipidoses have a variety of different symptoms and progressions. There are treatments for some—but not all—lipidoses. Treating the symptoms is always an integral part of lessening the impact of the disease. If parents have one child with a lipidoses disorder and are considering
Desnick, Robert J., and Michael M. Kaback, eds. Tay-Sachs Disease. San Diego, CA: Academic, 2001.
Vinken, Pierre J., and George W. Bruyn, eds. Neurodystrophies and Neurolipidoses. New York: Elsevier, 1996.
Enderlin, Carol, et al. "Gaucher Disease." American Journal of Nursing 103, no. 12 (December 2003): 50–62.
Futerman, Anthony H. et al. "New Directions in the Treatment of Gaucher Disease." Trends in Pharmacological Sciences 25, no. 3 (March 2004): 147–52.
Wilcox, William R., et al. "Long-term Safety and Efficacy of Enzyme Replacement Therapy for Fabry Disease." American Journal of Human Genetics 75, no. 1 (July 2004): 65–75.
National Organization for Rare Diseases. 55 Kenosia Avenue, PO Box 1968, Danbury, CT 06813-1968. (203) 744-0100 or 1-800-999-6673. Fax: (203) 798-2291. Web site: <www.rarediseases.org>.
Tish Davidson, A.M. Altha Roberts Edgren
|
|
Author Info: Tish Davidson A.M., Altha Roberts Edgren, Thomson Gale, Gale, Detroit, Gale Encyclopedia of Children's Health, 2006 |